AR038397A1 - Derivados de 3-aril-2,5-dihidroxi-1,4-benzoquinonas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen - Google Patents

Derivados de 3-aril-2,5-dihidroxi-1,4-benzoquinonas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen

Info

Publication number
AR038397A1
AR038397A1 ARP030100368A ARP030100368A AR038397A1 AR 038397 A1 AR038397 A1 AR 038397A1 AR P030100368 A ARP030100368 A AR P030100368A AR P030100368 A ARP030100368 A AR P030100368A AR 038397 A1 AR038397 A1 AR 038397A1
Authority
AR
Argentina
Prior art keywords
group
benzoquinonas
dihidroxi
aril
derivatives
Prior art date
Application number
ARP030100368A
Other languages
English (en)
Inventor
Alexandra Dassonville
Anne Breteche
Muriel Duflos
Baut Guillaume Le
Bruno Pfeiffer
Pierre Renard
Nigel Levens
Bernadette Husson-Robert
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR038397A1 publication Critical patent/AR038397A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/28—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of CHx-moieties
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/28—Quinones containing groups having oxygen atoms singly bound to carbon atoms with monocyclic quinoid structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Compuesto de fórmula (1) en la cual R1 y R2 idénticos o diferentes, representan cada uno un átomo de H o un grupo acilo o alquilo, Ar representa un grupo arilo o heteroarilo, A representa un grupo elegido entre:---C:::C---, estructura (2) , ---CR4=CR5--, R4 representa un átomo de H o un grupo alquilo, R5 representa un átomo de H o un grupo elegido entre alquilo, arilo, y heteroarilo,, R3 representa un grupo arilo, heteroarilo, diciclopropilmetilo o bencidrilo, o A-R3 representa un grupo naftilo eventualmente sustituido, a excepción de la 2,5-dihidro-3-(4-metoxifenil)-6-(2-feniletenil)-1,4-benzoquinona, la 2,5-dihidroxi-3-(4-metoxifenil)-o-(2-naftil)-1,4-benzoquinona, y la 2,5-dihidroxi-3-(2-naftil)-6-fenil-1,4-benzoquinona. Medicamentos.
ARP030100368A 2002-02-06 2003-02-06 Derivados de 3-aril-2,5-dihidroxi-1,4-benzoquinonas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen AR038397A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0201409A FR2835523B1 (fr) 2002-02-06 2002-02-06 Nouveaux derives de 3-aryl-2,5-dihydroxy-1,4-benzoquinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
AR038397A1 true AR038397A1 (es) 2005-01-12

Family

ID=27619936

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100368A AR038397A1 (es) 2002-02-06 2003-02-06 Derivados de 3-aril-2,5-dihidroxi-1,4-benzoquinonas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen

Country Status (21)

Country Link
US (1) US20050085644A1 (es)
EP (1) EP1472208A1 (es)
JP (1) JP4098248B2 (es)
KR (1) KR100605805B1 (es)
CN (1) CN1274655C (es)
AR (1) AR038397A1 (es)
AU (1) AU2003226860B9 (es)
BR (1) BR0307465A (es)
CA (1) CA2474533A1 (es)
EA (1) EA006775B1 (es)
FR (1) FR2835523B1 (es)
GE (1) GEP20063900B (es)
HK (1) HK1078566A1 (es)
MA (1) MA27103A1 (es)
MX (1) MXPA04007684A (es)
NO (1) NO20043532L (es)
NZ (1) NZ534099A (es)
PL (1) PL370773A1 (es)
UA (1) UA79448C2 (es)
WO (1) WO2003066561A1 (es)
ZA (1) ZA200405446B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103058846B (zh) * 2013-01-17 2014-07-30 福州大学 一种源于棘孢曲霉的苯醌衍生物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK34185A (da) * 1984-01-26 1985-07-27 Otsuka Pharma Co Ltd 1,4-benzoquinon-derivater og benzen-derivater samt fremgangsmaade til fremstilling af saadanne derivater
US7057052B2 (en) * 2002-09-26 2006-06-06 Duke University Heterocyclic quinones as pharmaceutical agents

Also Published As

Publication number Publication date
JP2005517001A (ja) 2005-06-09
KR100605805B1 (ko) 2006-08-01
ZA200405446B (en) 2005-07-08
AU2003226860B2 (en) 2008-06-26
NZ534099A (en) 2006-09-29
KR20040086352A (ko) 2004-10-08
UA79448C2 (en) 2007-06-25
AU2003226860B9 (en) 2008-08-14
EA200400992A1 (ru) 2005-02-24
FR2835523A1 (fr) 2003-08-08
FR2835523B1 (fr) 2004-04-16
EA006775B1 (ru) 2006-04-28
PL370773A1 (en) 2005-05-30
CN1274655C (zh) 2006-09-13
US20050085644A1 (en) 2005-04-21
EP1472208A1 (fr) 2004-11-03
GEP20063900B (en) 2006-08-10
NO20043532L (no) 2004-08-24
BR0307465A (pt) 2004-11-09
CN1628088A (zh) 2005-06-15
MA27103A1 (fr) 2004-12-20
AU2003226860B8 (en) 2008-07-10
AU2003226860A1 (en) 2003-09-02
JP4098248B2 (ja) 2008-06-11
HK1078566A1 (en) 2006-03-17
CA2474533A1 (fr) 2003-08-14
MXPA04007684A (es) 2005-07-13
WO2003066561A1 (fr) 2003-08-14

Similar Documents

Publication Publication Date Title
AR044650A1 (es) Derivados de tiofeno - pirimidinona y su uso en la terapia de enfermedades que requieren la inhibicion de la enzima 17b-hidroxiesteroide-dehidrogenasa.
ES2040276T3 (es) Derivados de la indolizina, procedimiento para su preparacion y composiciones que los contienen.
CO5251381A1 (es) Derivados de adamantano, un proceso para su preparacion y composiciones farmaceuticas que los contienen
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
CO5031249A1 (es) Pirrol substituido-2-indolinonas inhibidoras de proteinci-nasas
AR021380A1 (es) COMPUESTOS DIPEPTIDOS CON ELEVADA ACTIVIDAD FUNGUICIDA, SU EMPLEO EN AGRONOMIA, COMPOSICIONES FUNGUICIDAS QUE CONTIENEN A DICHOS COMPUESTOS, PROCEDIMIENTO PARA LA PREPARACIoN DE DICHAS COMPOSICIONES Y MÉTODO PARA COMBATIR INFECCIONES DE HONGOS EMPLEANDO EL COMPUESTO DIPÉPTIDO.
UY29703A1 (es) "inhibidores macrocíclicos del virus de la hepatitis c"
NO20053335L (no) 2-aminokarbonyl-kinolinforbindelser som blodplateadenosindifosfatreseptorer.
GT200300268A (es) Nuevos derivados fluoroglucosidos heterociclicos, medicamentos que contienen estos compuestos y el uso de los mismos
CO4950513A1 (es) Compuestos de pirazina
CO5611155A2 (es) Uso de derivado de indolopirrolocarbazol y otro agente anticanceroso en combinacion
ES2192031T3 (es) Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos.
ES2097142T3 (es) Derivados de indol, su preparacion y medicamento que los contiene destinado para la prevencion y para el tratamiento de la nefritis.
HUP0402235A2 (hu) 4,4-Difluor-1,2,3,4-tetrahidro-5H-1-benzazepin-származékok és ezek sói és ezeket tartalmazó gyógyszerkészítmények
AR039601A1 (es) Derivados de nitrosodifenilamina y composiciones farmaceuticas que los comprenden como medicamentos que se pueden utilizar en el tratamiento de patologias que se caracterizan por estres oxidativo
ES2253568T3 (es) Compuestos heterociclicos para el uso en el tratamiento de los trastornos de las vias urinarias.
AR045155A1 (es) Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos
AR022413A1 (es) Utilizacion de derivados de piridazino(4,5-b)indol-1-acetamida, para la preparacion de medicamentos destinados a las enfermedades del sistema nerviosocentral
CO5660264A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR002016A1 (es) Derivados de 3-fenilisoquinoleina-1-(2h)-ona, procedimiento para su preparacion y medicamento y composicion farmaceutica que los contienen.
CO5550494A2 (es) Derivados de diamina, proceso para producir los derivados de diamina, y fungicidas que contienen los derivados de diamina como ingrediente activo
CO5070654A1 (es) Derivados de acidos fenilaminoalquilcarboxilicos y composiciones farmaceuticas que los comprenden
AR038397A1 (es) Derivados de 3-aril-2,5-dihidroxi-1,4-benzoquinonas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen
CO5590858A2 (es) Composicion fungicida basada en un derivado de piridilmetilbenzamida e iprovalicarb

Legal Events

Date Code Title Description
FA Abandonment or withdrawal